Project Details
Description
A Phase I, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Subcutaneous Doses of rAvPAL-PEG in Subjects With Phenylketonuria
| Status | Finished |
|---|---|
| Effective start/end date | 12/18/07 → 12/31/09 |
Funding
- BIOMARIN PHARMACEUTICAL, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.